Alpine Global Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
Other funds holding TRML
RCM
ACA
BOCH
TCM
QUSVM
RI
QF
Alpine Global Management's TRML Position: Q3 2024 in Review
Alpine Global Management sold out of Tourmaline Bio (TRML) in Q3 2024, closing a stake of 22,648 shares — an estimated $291K sold.
Alpine Global Management first reported a position in TRML in Q2 2024 and held it in 1 quarter. The position peaked at $291K in Q2 2024. 92 funds tracked by Wall St. Rank hold TRML as of Q3 2024.
- Alpine Global Management reported no remaining Tourmaline Bio position as of Q3 2024 after selling out during the quarter.
- Alpine Global Management sold 22,648 Tourmaline Bio shares in Q3 2024, an estimated $291K.
- Alpine Global Management first reported a position in Tourmaline Bio in Q2 2024 and held it in 1 quarter.
- Alpine Global Management's Tourmaline Bio position peaked at $291K in Q2 2024.
- 92 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2024.
Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.